Qu Biologics Receives Accelerating Clinical Trial (ACT) Funding for PERIOP-06 Clinical Trial
ACT was founded in 2022 and is funded by the Canadian Institutes of Health Research (CIHR) Clinical Trials Fund to support clinical trials across Canada.
- ACT was founded in 2022 and is funded by the Canadian Institutes of Health Research (CIHR) Clinical Trials Fund to support clinical trials across Canada.
- ACT brings together hundreds of researchers from 28 networks, 11 trial units, patient-partners, the biotechnology industry, government, and research ethics experts from across Canada.
- It was one of only three clinical trials in Canada anticipated to receive this funding in a very competitive process.
- Please subscribe here to receive future news and updates from Qu Biologics.